Evotec surprises, share price rises sharply - | but is it enough?: Evotec's share price rises after better-than-expected nine-month figures ...
deraktionaer.de/artikel/pharma-biotech/evotec-ueberrascht-aktie-zieht-kraeftig-an-doch-reicht-das-20416264.html
Evotec: Share price plummets again – | the details: Evotec's stock falls 6% after disappointing Q2 figures: revenue declines by 16.2% ...
deraktionaer.de/artikel/pharma-biotech/evotec-aktie-rauscht-erneut-nach-unten-die-details-20406712.html
Evotec stock is being dismantled – | losses of up to €105 million are looming: Evotec has drastically lowered its annual targets. Instead of operating profit ...
wallstreet-online.de/nachricht/21106147-viertel-boersenwert-futsch-evotec-aktie-zerlegt-105-millionen-euro-verlust-drohen
Evotec slips again - | this is the reason: Evotec shares fall over 8% after the placement of convertible bonds worth €116 million.
deraktionaer.de/artikel/pharma-biotech/evotec-rutscht-erneut-ab-das-ist-der-grund-20400955.html
Biotech company: Evotec receives funding from the Gates Foundation: Evotec secures nearly $10 million from the Bill & Melinda Gates Foundation for new ...
manager-magazin.de/unternehmen/evotec-gates-stiftung-foerdert-tuberkuloseforschung-mit-zehn-millionen-dollar-a-6de90f7a-4704-46e0-b849-0f1f72b73a95
Evotec Reports Earnings, Stock Makes a U-Turn: Evotec’s stock recovers after weak quarterly results. Despite operating losses and a decline in revenue ...
deraktionaer.de/artikel/pharma-biotech/evotec-mit-zahlen-aktie-mit-kehrtwende-20400395.html
Evotec: Acquisition and Figures - | Shares Continue to Rise: Evotec benefits from the Tubulis sale to Gilead. Q4 revenue increases by 14% to €253.3 million ...
deraktionaer.de/artikel/pharma-biotech/evotec-uebernahme-und-zahlen-aktie-legt-weiter-zu-20398573.html
Evotec stock falls and falls - | lowest level since 2016!: Evotec stock plunges to 10-year low, cost-cutting measures planned.
deraktionaer.de/artikel/aktien/evotec-aktie-faellt-und-faellt-tiefster-stand-seit-2016-20397014.html
Evotec shares jump to the top of the SDAX: Here's why: Evotec shares rise by 8% after a "Buy" recommendation from Berenberg with a target price of €10.
deraktionaer.de/artikel/pharma-biotech/evotec-aktie-springt-an-die-sdax-spitze-das-ist-der-grund-20394701.html
Evotec after recent rally - | this is important now: Evotec receives Gates funding for AI development of cost-effective antibodies.
deraktionaer.de/artikel/pharma-biotech/evotec-nach-juengster-rally-das-ist-jetzt-wichtig-20393144.html
